NO20030115D0 - Kontrastmiddel - Google Patents

Kontrastmiddel

Info

Publication number
NO20030115D0
NO20030115D0 NO20030115A NO20030115A NO20030115D0 NO 20030115 D0 NO20030115 D0 NO 20030115D0 NO 20030115 A NO20030115 A NO 20030115A NO 20030115 A NO20030115 A NO 20030115A NO 20030115 D0 NO20030115 D0 NO 20030115D0
Authority
NO
Norway
Prior art keywords
imaging agents
formula
moiety
angiotensin
affinity
Prior art date
Application number
NO20030115A
Other languages
English (en)
Norwegian (no)
Inventor
Magne Solbakken
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20030115A priority Critical patent/NO20030115D0/no
Publication of NO20030115D0 publication Critical patent/NO20030115D0/no
Priority to AT04701136T priority patent/ATE425770T1/de
Priority to EP04701136A priority patent/EP1581262B1/fr
Priority to US10/541,949 priority patent/US7919071B2/en
Priority to CNA2004800019549A priority patent/CN1723043A/zh
Priority to PCT/NO2004/000002 priority patent/WO2004062568A2/fr
Priority to DE602004020049T priority patent/DE602004020049D1/de
Priority to JP2006500737A priority patent/JP2006517539A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Steroid Compounds (AREA)
NO20030115A 2003-01-09 2003-01-09 Kontrastmiddel NO20030115D0 (no)

Priority Applications (8)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel
AT04701136T ATE425770T1 (de) 2003-01-09 2004-01-09 Kontrastmittel
EP04701136A EP1581262B1 (fr) 2003-01-09 2004-01-09 Agent de contraste
US10/541,949 US7919071B2 (en) 2003-01-09 2004-01-09 Contrast agent
CNA2004800019549A CN1723043A (zh) 2003-01-09 2004-01-09 造影剂
PCT/NO2004/000002 WO2004062568A2 (fr) 2003-01-09 2004-01-09 Agent de contraste
DE602004020049T DE602004020049D1 (de) 2003-01-09 2004-01-09 Kontrastmittel
JP2006500737A JP2006517539A (ja) 2003-01-09 2004-01-09 造影剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Publications (1)

Publication Number Publication Date
NO20030115D0 true NO20030115D0 (no) 2003-01-09

Family

ID=19914362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Country Status (8)

Country Link
US (1) US7919071B2 (fr)
EP (1) EP1581262B1 (fr)
JP (1) JP2006517539A (fr)
CN (1) CN1723043A (fr)
AT (1) ATE425770T1 (fr)
DE (1) DE602004020049D1 (fr)
NO (1) NO20030115D0 (fr)
WO (1) WO2004062568A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
WO2005049095A2 (fr) * 2003-11-24 2005-06-02 Amersham Health As Agent de contraste
DE602005017475D1 (de) 2004-03-04 2009-12-17 Ge Healthcare As Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie
FR2902428B1 (fr) * 2006-06-15 2008-08-15 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN101536563A (zh) * 2006-11-13 2009-09-16 Lm爱立信电话有限公司 无线电信系统
ATE471724T1 (de) * 2006-12-11 2010-07-15 Ge Healthcare As Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung
TW201215388A (en) * 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2019134765A1 (fr) 2018-01-08 2019-07-11 Julius-Maximilians-Universitaet Wuerzburg Analogue de sartan

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365378A (ja) * 1989-08-04 1991-03-20 Tokyo Tatsuno Co Ltd 複写伝票
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
JPH09165378A (ja) 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk Ｎ１−［１８ｆ］フルオロベンジル複素環化合物およびそれらの製造法
EP0971747B1 (fr) * 1996-10-28 2005-12-28 Amersham Health AS Agents de contraste
EP1272507B1 (fr) 2000-04-12 2005-06-29 Amersham Health AS Composes a base de peptides
AU6972901A (en) * 2000-05-31 2001-12-11 Mayo Foundation Cobalamin compounds useful as cardiovascular agents and as imaging agents
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
NZ530156A (en) * 2001-07-10 2007-04-27 Ge Healthcare As Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates

Also Published As

Publication number Publication date
ATE425770T1 (de) 2009-04-15
US20070020176A1 (en) 2007-01-25
DE602004020049D1 (de) 2009-04-30
WO2004062568A2 (fr) 2004-07-29
EP1581262B1 (fr) 2009-03-18
US7919071B2 (en) 2011-04-05
EP1581262A2 (fr) 2005-10-05
WO2004062568A3 (fr) 2004-09-30
JP2006517539A (ja) 2006-07-27
CN1723043A (zh) 2006-01-18

Similar Documents

Publication Publication Date Title
MXPA04000173A (es) Compuestos basados en peptidos.
NO20073039L (no) Kontrastmidler
ATE425770T1 (de) Kontrastmittel
SG149895A1 (en) Contrast agents for myocardial perfusion imaging
DK1272507T3 (da) Integrinbindende peptidderivater
WO2003105757A3 (fr) Methodes et compositions de liaison dependant du milieu d'un agent cible a une cible
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
HK1097278A1 (en) Imaging agents
ATE314097T1 (de) Kontrastmittel
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
WO1998018497A3 (fr) Agents de contraste
HUP0301835A2 (hu) Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva
DE602005024279D1 (de) 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren
GB0326546D0 (en) Inhibitor imaging agents
ATE376428T1 (de) Metallkomplexverbindungen
DE69841322D1 (de) Hepatitis c rezeptorprotein cd81
WO2007064661A3 (fr) Conjugues chelatant metalliferes bifonctionnels
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
TW200616950A (en) Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (yc-1) as anti-platelet agents
NO20033115D0 (no) Peptid-baserte forbindelser
ATE480552T1 (de) Stq-peptide
WO2005049095A3 (fr) Agent de contraste
DK1485090T3 (da) Kombinationer omfattende et epothilonderivat og en imidazotetrazinon
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.
TW200628170A (en) Contrast agents for myocardial perfusion imaging